Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-09

Clinical Trial Update: Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating palonosetron and dexamethasone with or without dronabinol for prevention of chemotherapy-induced nausea and vomiting; results completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Dronabinol (dronabinol)
  • Palonosetron (palonosetron)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chemotherapy-induced Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Status: COMPLETED | Results posted: 2020-10-09